JPH01501627A - 乾癬治療用組成物 - Google Patents

乾癬治療用組成物

Info

Publication number
JPH01501627A
JPH01501627A JP63500719A JP50071988A JPH01501627A JP H01501627 A JPH01501627 A JP H01501627A JP 63500719 A JP63500719 A JP 63500719A JP 50071988 A JP50071988 A JP 50071988A JP H01501627 A JPH01501627 A JP H01501627A
Authority
JP
Japan
Prior art keywords
united states
tin
usp
treatment
week
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63500719A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0585523B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
カパス，アタラー
ドラモンド，ジョージ　エス．
エムテスタム，レナート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University filed Critical Rockefeller University
Publication of JPH01501627A publication Critical patent/JPH01501627A/ja
Publication of JPH0585523B2 publication Critical patent/JPH0585523B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP63500719A 1986-12-08 1987-12-07 乾癬治療用組成物 Granted JPH01501627A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US93882286A 1986-12-08 1986-12-08
US938,822 1986-12-08
US07/125,011 US4782049A (en) 1986-12-08 1987-12-02 Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
US125,011 1987-12-02

Publications (2)

Publication Number Publication Date
JPH01501627A true JPH01501627A (ja) 1989-06-08
JPH0585523B2 JPH0585523B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-12-07

Family

ID=26823181

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63500719A Granted JPH01501627A (ja) 1986-12-08 1987-12-07 乾癬治療用組成物

Country Status (12)

Country Link
US (1) US4782049A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0295280B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH01501627A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR920002330B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE63815T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU597144B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1302253C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3770465D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK443088A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE63507B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH25224A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1988004174A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7777028B2 (en) 2002-06-04 2010-08-17 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
US7960371B2 (en) 2006-10-04 2011-06-14 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
US8735574B2 (en) 2011-03-30 2014-05-27 Infacare Pharmaceutical Corporation Methods for synthesizing metal mesoporphyrins

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333831B1 (en) * 1987-09-08 1992-07-15 The Rockefeller University Use of metalloporphyrins to reverse the toxic effect of tumor therapy
GR1000182B (el) * 1988-03-28 1992-01-20 Univ Rockefeller Χρησιμοποιηση πρωτοπορφυρινης κασσιτερου και μεσοπορφυρινης κασσιτερου στην παρασευη φαρμακευτικων συνθεσεων για την αγωγη της ψωριασης.
US4997828A (en) * 1989-02-14 1991-03-05 The Rockefeller University Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin
US5192757A (en) * 1990-12-20 1993-03-09 Glaxo Inc. Cobalt porphyrins
US5149697A (en) * 1991-04-18 1992-09-22 Glaxo Inc. Cobalt porphyrin pharmaceutical compositions
WO1995017893A1 (en) * 1993-12-28 1995-07-06 New York Blood Center Methods for preventing or treating hiv-1 or hiv-2 infection
TW247876B (en) 1993-12-28 1995-05-21 New York Blood Ct Inc Pharmaceutical compositions for prevention or treating HIV-1 or HIV-2 infection
EP0765161A2 (en) * 1994-06-02 1997-04-02 Bar-Ilan University Synergistic antibiotic compositions containing a perphyrin and an antibiotic
FR2727862B1 (fr) * 1994-12-07 1997-03-28 Holzmann Stephane Produits cosmetiques et/ou d'hygiene corporelle et/ou dermatologiques constitues d'une phase aqueuse isotonique et/ou d'une phase aqueuse osmotique
US5929064A (en) * 1995-08-02 1999-07-27 Warner-Lambert Company Amino acid complexes of cobalt (III) mesoporphyrin IX and cobalt (III) protoporphyrin IX
AU2003237349B2 (en) 2002-06-04 2010-06-03 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin halide compounds
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation
US20060222668A1 (en) * 2005-04-01 2006-10-05 Wellspring Pharmaceutical Corporation Stannsoporfin compositions, drug products and methods of manufacture
AU2015324103C1 (en) 2014-09-29 2020-08-20 Fred Hutchinson Cancer Center Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
CA3225692A1 (en) * 2021-07-12 2023-01-19 Donald Jeffrey Keyser Metal protoporphyrin for treatment of bk virus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454152A (en) * 1980-05-07 1984-06-12 Hoffmann-La Roche Inc. Methoxsalen dosage forms
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
US4692439A (en) * 1986-06-20 1987-09-08 The Rockefeller University Therapeutic use of tin diiododeuteroporphyrin

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
COMPUTER GRAPHICS AND IMAGE PROCESSING=1981 *
SECOND USA-JAPAN COMPUTER CONFERENCE PROCEEDINGS=1975 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8178664B2 (en) 2002-06-04 2012-05-15 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
US7777028B2 (en) 2002-06-04 2010-08-17 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
US9107927B2 (en) 2006-10-04 2015-08-18 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
US8530458B2 (en) 2006-10-04 2013-09-10 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
US8835416B2 (en) 2006-10-04 2014-09-16 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
US7960371B2 (en) 2006-10-04 2011-06-14 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
US9517239B2 (en) 2006-10-04 2016-12-13 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
US9902745B2 (en) 2006-10-04 2018-02-27 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
US10273255B2 (en) 2006-10-04 2019-04-30 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
US10662209B2 (en) 2006-10-04 2020-05-26 Mallinckrodt Hospital Products IP Limited High-purity large-scale preparation of stannsoporfin
US11078220B2 (en) 2006-10-04 2021-08-03 Mallinckrodt Hospital Products IP Limited High-purity large-scale preparation of stannsoporfin
US8735574B2 (en) 2011-03-30 2014-05-27 Infacare Pharmaceutical Corporation Methods for synthesizing metal mesoporphyrins
US9181285B2 (en) 2011-03-30 2015-11-10 Infacare Pharmaceutical Corporation Methods for synthesizing metal mesoporphyrins
US9688705B2 (en) 2011-03-30 2017-06-27 Infacare Pharmaceutical Corporation Methods for synthesizing metal mesoporphyrins
US10533024B2 (en) 2011-03-30 2020-01-14 Mallinckrodt Hosptial Products Ip Limited Methods for synthesizing metal mesoporphyrins

Also Published As

Publication number Publication date
DK443088D0 (da) 1988-08-08
EP0295280A1 (en) 1988-12-21
AU1081288A (en) 1988-06-30
IE873323L (en) 1988-06-08
IE63507B1 (en) 1995-05-03
EP0295280A4 (en) 1989-02-21
US4782049A (en) 1988-11-01
JPH0585523B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-12-07
EP0295280B1 (en) 1991-05-29
DE3770465D1 (de) 1991-07-04
ATE63815T1 (de) 1991-06-15
KR890700026A (ko) 1989-03-02
WO1988004174A1 (en) 1988-06-16
CA1302253C (en) 1992-06-02
DK443088A (da) 1988-08-08
AU597144B2 (en) 1990-05-24
PH25224A (en) 1991-03-27
KR920002330B1 (ko) 1992-03-21

Similar Documents

Publication Publication Date Title
JPH01501627A (ja) 乾癬治療用組成物
US6524623B1 (en) Therapeutic compositions and methods of use thereof
CN108853312B (zh) 聚桂醇外用凝胶及其制备方法
WO1993000873A1 (en) Composition and method for transdermal delivery of diclofenac
CN105142728A (zh) 用于治疗表面创伤的组合物和方法
JP2020510042A (ja) 光線角化症を治療および／または予防する方法
US4369190A (en) Analgesic composition and use thereof to ameliorate intractable pain
JPH01503146A (ja) 身体組織の治療方法および身体組織への医薬の投与方法
US7442690B2 (en) Topical treatment for psoriasis
ZA200601054B (en) Method and composition for treating burned skin
EP0780129A2 (en) Adrenal cortical steroid containing external therapeutic composition for dermatitis
US5331012A (en) Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
JP2860550B2 (ja) 急性皮膚炎症治療剤
RU2132187C1 (ru) Способ лечения заболеваний кожи и слизистых оболочек и магнитоактивное органическое соединение железа, используемое в нем
JPH0653664B2 (ja) プソラレン誘導体含有薬剤
EP1517691B1 (de) Verwendung von dopamin-rezeptor-agonisten zur behandlung von hautgeschwülsten, warzen und narben
US20040039042A1 (en) Method of transdermal drug delivery
JPS6277318A (ja) 熱傷治療剤
KR20020035131A (ko) 덱스라족산의 건선 치료 용도
WO2025077886A1 (zh) 治疗和/或预防日光性角化病的化合物及方法
WO2025077883A1 (zh) 治疗和/或预防皮肤癌或其癌前病变的化合物及方法
WO2025077888A1 (zh) 一种适合外用的化合物及药物组合物
WO2025081549A1 (zh) 一种黄芩素外用制剂及其在特应性皮炎治疗中的应用
WO2014131096A1 (pt) Formulação obtida pela associação do antiviral aciclovir, com vitamina b6 e anti-histamínico para tratamento do herpes e meio de aplicação
US20190000822A1 (en) Chlorine or bromine salts of cetylpyridinium for use in the treatment of cutaneous and acute porphyrias and psoriasis

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees